J.M., Sangrujee, N., Wiktor, S.Z., 2012. Costeffectiveness of tuberculosis diagnostic strategies to reduce early mortality among persons with advanced HIV infection initiating antiretroviral therapy. J. AIDS, 60(1) doi: 10.1097/QAI.0b013e318246538f18246538f Ananthanarayan, R. dan Peniker, C.K.J., 2000. Text Book of Microbiology Sixth Edition. Chennai: Longman Private Limited. Blakemore, R., Story, E., Helb, D., Kop, J., Banada, P., Owens, M.R., Chakravorty, S., Jones, M., Alland D., 2010. Evaluation of the Analytical Performance of the Xpert MTB/RIF Assay. J.Clin. Microbiol, 48(7) p. 24952501 Brunton, L.L., Blumenthal, D., Buxton, I., Parker, K., 2008. Goodman and Gillmanss Manual Pharmacology and Therapeutic. New York: McGrawHill Companies Chang, K., Lu, W., Wang, J., Zhang, K., Jia, S., Li F., Deng, S., Chen M. 2012. Rapid and effective diagnosis of tuberculosis and rifampicin resistance with Xpert MTB/RIF assay: A metaanalysis. J. Inf. (2012)64, 580-588. Depkes RI, 2010. Pedoman Nasional Penanggulangan Tuberkulosis. Jakarta: Depkes RI. Gemert, W.V., Mirzayev, F., Iragena, J., Gilpin, C., Weyer, K. 2012. Update on the Global Roll-Out of Xpert MTB/RIF.The Stop TB department WHO. Jawetz, E. & Melnick, J., 2010. Review of Medical Microbiology. 15th ed. California: Lange Medical Publication. Katzung, B.G., 2007. Basic and Clinical Pharmacology. 10th ed. Singapura: Mc. Graw Hill. Kemenkes.2012.Petunjuk Teknis Pemeriksaan Biakan, Identifikasi, Dan Uji Kepekaan Mycobacterium tuberculosis pada Media Padat.Jakarta: Kemenkes Lawn, S.D, Brooks, S.V., Kranzer, K., Nicol, M.P., Whitelaw, A., Vogt, M., Bekker, L., Wood, R. 2011. Screening for HIV-Associated Tuberculosis and Rifampicin Resistance before Antiretroviral Therapy Using the Xpert MTB/RIF Assay: A Prospective Study . PLoS Med 8(7): e1001067. doi:10.1371/journal.pmed.1001067
Lu, C., Liu, Q., Sarma, A., Flitzpatrick, C., Falzon,
D., Mitnick, C.D.2013. A Systematic Review of Reported Cost for Smear and Culture Tests during Multidrug-Resistant Tuberculosis Treatment. PLoS ONE 8(2): e56074. doi:10.1371/journal.pone.0056074 Mani, C., Selvakumar, N., Narayanan, S., dan Narayanan P.R. 2001. Mutations in the rpoBGene of Multidrug-Resistant. Jurnal of Clinical Microbiology, 39(8) p. 29872990.doi: 10.1128/JCM.39.8.29872990.2001 MacEneaney, P.M., Malone, D.E.,2000. The Meaning of Diagnostic Test Results: A Spreadsheet for Swift Data Analysis. J. Clin. Rad. (2000) 55, 227-235 Murray, P.R., Baron, E.J., Pfaller, M.A., Tenover F.C., Volken, R.H. 2007. Manual Clinical Microbiology (9 th). Washington, D.C: asm press Mustakawati, D.E. 2012. Indonesias Experience in Introducing Xpert MTB/RIF. France : Global Laboratory Initiative (GLI). Ndungga, L., Cleeff, M.V., Juma, E., Kimwomi, J., Githui, W., Oskam, L., Schuitema, A., Soolingen, D.V., Nganga, L., Kibuga, D., Odhiambo, J., Klatser, P.2004.Comparison of PCR with the Routine Procedure for Diagnosis of Tuberculosis in a Population with High Prevalences of Tuberculosis and Human Immunodeficiency Virus.J. Clin. Microbiol. 42(3) p.1012-1015 doi: 10.1128/JCM.42.3.10121015.2004 Piatek, A. S., Van Cleeff, M., Alexander, H., Coggin, W. L., Rehr, M., Van Kampen, S., & Mukadi, Y. 2013.GeneXpert for TB diagnosis: planned and purposeful implementation. Global Health: Science and Practice, 1(1), 18-23. Sjahrurachman, A., 2010. Diagnosis Multi Drug Resistant Mycobacterium Tuberculosis. Jakarta: Departemen Mikrobiologi FKUI. Sudoyo, A.W., Setiyohadi, B., Alwi, I., Simadibarata, M., Setiati, S. 2009. Buku Ajar Ilmu Penyakit Dalam. Jakarta: Interna Publishing. Tenover, F. 2009. Xpert MTB/RIF Two-hour detection of MTB and resistance to rifampicin. California : Cepheid
Theron, G. 2011.Evaluation of the Xpert MTB/RIF assay
for the diagnosis of pulmonary tuberculosis in a high HIV prevalence setting.AJRCCM Articles in Press. doi:10.1164/rccm.201101-0056OC UNAIDS, 2013. report on the global AIDS epidemic. Joint United Nations Programme on HIV/AIDS (UNAIDS). WHO, 2013. Global Tuberculosis Report. France: WHO.